Status:
COMPLETED
Study of ONO-8539 in Patients With Overactive Bladder
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Conditions:
Overactive Bladder
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
The objective of this study is to investigate efficacy, safety and tolerability of ONO-8539 in patients with overactive bladder.
Eligibility Criteria
Inclusion
- Patients with medical history of Overactive Bladder symptoms for \> 6 months
Exclusion
- Patients who have a history or presence of other significant diseases, which in the opinion of the investigator, might compromise the patient's safety or the evaluation of the study results
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
435 Patients enrolled
Trial Details
Trial ID
NCT00876421
Start Date
April 1 2009
Last Update
June 14 2012
Active Locations (50)
Enter a location and click search to find clinical trials sorted by distance.
1
Brno, Czechia
2
Jindřichův Hradec, Czechia
3
Olomouc, Czechia
4
Opava, Czechia